Physician profile
Daniel J Carson
NPI 1841853918
$592.50
in general payments reported to CMS, 2019-2025
8 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $77.89 · 2023: $76.51 · 2024: $260 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $184.20 | 2024-2025 | Intracept |
| Spr Therapeutics, INC | $178.16 | 2022-2024 | Sprint Pns System |
| Stryker Corporation | $84.85 | 2023-2024 | Spinejack |
| Biotronik Nro, INC. | $49.10 | 2025 | Prospera |
| Medtronic, INC. | $35.32 | 2023 | Intellis Adaptivestim |
| Biocomposites INC | $23.24 | 2025 | Stimulan |
| Stimwave Technologies Incorporated | $19.39 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.